Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 1992, Suchdauer: 1.08s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Having More Tender Than Swollen Joints is Associated With Worse Function and Work Impairment in Patients With Early Rheumatoid Arthritis

von Charis F. Meng ; Yvonne Lee ; Orit Schieir ; et al.

ACR Open Rheumatology, Vol 6, Iss 6, Pp 347-355 (2024)

Schlagworte: Diseases of the musculoskeletal system; RC925-935
- View full text via DOI
Merkliste

2
Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47

von Edward Keystone ; Josef S Smolen ; Gerd R Burmester ; et al.

RMD Open, Vol 10, Iss 4 (2024)

Schlagworte: Medicine
- View full text via DOI
Merkliste

3
Pharmacokinetic equivalence of CT‐P17 to high‐concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects

von Kyung‐Sang Yu ; In‐Jin Jang ; Hyeong‐Seok Lim ; et al.

Clinical and Translational Science, Vol 14, Iss 4, Pp 1280-1291 (2021)

Schlagworte: Therapeutics. Pharmacology; RM1-950; Public aspects of medicine; RA1-1270
- View full text via DOI
Merkliste

4
Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study

von Jonathan Kay ; Janusz Jaworski ; Rafal Wojciechowski ; et al.

Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)

Schlagworte: Adalimumab; Biologics; Biosimilars; Comparative effectiveness; Immunogenicity; Monoclonal antibodies; Diseases of the musculoskeletal system; RC925-935
- View full text via DOI
Merkliste

5
Comorbidities Before and After the Diagnosis of Rheumatoid Arthritis: A Matched Longitudinal Study

von Mark R. Tatangelo ; George Tomlinson ; Edward Keystone ; et al.

ACR Open Rheumatology, Vol 2, Iss 11, Pp 648-656 (2020)

Schlagworte: Diseases of the musculoskeletal system; RC925-935
- View full text via DOI
Merkliste

6
Joint Estimation of Remission and Response for Methotrexate‐Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta‐Analysis

von Gyanendra Pokharel ; Rob Deardon ; Cheryl Barnabe ; et al.

ACR Open Rheumatology, Vol 1, Iss 8, Pp 471-479 (2019)

Schlagworte: Diseases of the musculoskeletal system; RC925-935
- View full text via DOI
Merkliste

7
Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open‐Label, Long‐Term Extension Studies up to 9.5 Years

von Janet E. Pope ; Edward Keystone ; Shahin Jamal ; et al.

ACR Open Rheumatology, Vol 1, Iss 2, Pp 73-82 (2019)

Schlagworte: clinical trial; DMARDs; rheumatoid arthritis; risk factors; Diseases of the musculoskeletal system; RC925-935
- View full text via DOI
Merkliste

8
Health care costs of rheumatoid arthritis: A longitudinal population study.

von Mark Tatangelo ; George Tomlinson ; J Michael Paterson ; et al.

PLoS ONE, Vol 16, Iss 5, p e0251334 (2021)

Schlagworte: Medicine; Science
- View full text via DOI
Merkliste

9
Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis

von Edward Keystone ; Josef S Smolen ; Paul Emery ; et al.

RMD Open, Vol 6, Iss 1 (2020)

Schlagworte: Medicine
- View full text via DOI
Merkliste

10
Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study

von Haraoui, Boulos ; Khraishi, Majed ; Choquette, Denis ; et al.

Rheumatology and Therapy. 11(6):1629-1648
- Zum Volltext in PubMed Central
Merkliste

11
Unravelling the Mystery Between Structure and Sustained Clinical Outcomes

von Edward Keystone ; Leigh Revers ; Thomas Dörner

European Medical Journal Rheumatology, Vol 3, Iss 1, Pp 48-56 (2016)

Schlagworte: EULAR; European League Against Rheumatism; Diseases of the musculoskeletal system; RC925-935
- Zum Volltext in DOAJ
Merkliste

12
“From Where I Stand”: using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ)

von Bartlett, Susan J. ; Bykerk, Vivian P. ; Schieir, Orit ; et al.

Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation - An Official Journal of the International Society of Quality of Life Research. 32(5):1307-1318
- Zum Volltext (via ReDI)
Merkliste

13
Statin Use for Primary Cardiovascular Disease Prevention Is Low in Inflammatory Arthritis

von Kuriya, Bindee ; Akhtari, Shadi ; Movahedi, Mohammad ; et al.

In Canadian Journal of Cardiology August 2022 38(8):1244-1252
- View full text via DOI
Merkliste

14
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis

von Ishigaki, Kazuyoshi ; Sakaue, Saori ; Terao, Chikashi ; et al.

Nature Genetics. 54(11):1640-1651
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

15
Methotrexate withdrawal in patients with rheumatoid arthritis who achieve low disease activity with tofacitinib modified-release 11 mg once daily plus methotrexate (ORAL Shift): a randomised, phase 3b/4, non-inferiority trial

von Cohen, Stanley B ; Pope, Janet ; Haraoui, Boulos ; et al.

In The Lancet Rheumatology September 2019 1(1):e23-e34
- View full text via DOI
Merkliste

16
Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19

von Holman, Andrew J. ; Keystone, Edward ; Choy, Ernest ; et al.

Rheumatology and Therapy. 9(1):305-307
- Zum Volltext in PubMed Central
Merkliste

17
Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study

von Wells, Alvin F. ; Jia, Bochao ; Xie, Li ; et al.

Rheumatology and Therapy. 8(2):987-1001
- Zum Volltext in PubMed Central
Merkliste

18
A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population

von Kivitz, Alan J. ; Cohen, Stanley ; Keystone, Edward ; et al.

In Seminars in Arthritis and Rheumatism December 2018 48(3):406-415
- View full text via DOI
Merkliste

19
Additional file 1 of Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study

von Jonathan Kay (7327241) ; Janusz Jaworski (2806834) ; Rafal Wojciechowski (10106108) ; et al.

Schlagworte: Medicine; Physiology; Ecology; Immunology; Mathematical Sciences not elsewhere classified; Adalimumab; Biologics; Biosimilars; Comparative effectiveness; Immunogenicity; Monoclonal antibodies; Rheumatoid arthritis; Safety; Tumor necrosis factor inhibitors
- View full text via BASE
Merkliste

20
Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis

von Smolen, Josef S. ; Kang, Young Mo ; Yoo, Wan-Hee ; et al.

Arthritis Research & Therapy. 22(1)
- Zum Volltext in PubMed Central
Merkliste

21
Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome

von Harris, Valerie M. ; Sharma, Rohan ; Cavett, Joshua ; et al.

In Clinical Immunology July 2016 168:25-29
- View full text via DOI
Merkliste

22
Fibrocyte and T cell interactions promote disease pathogenesis in rheumatoid arthritis

von Galligan, Carole L. ; Keystone, Edward C. ; Fish, Eleanor N.

In Journal of Autoimmunity May 2016 69:38-50
- View full text via DOI
Merkliste

23

Dieses Ergebnis aus CINAHL kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.

Merkliste

24
Perspectives in targeted therapy

von Keystone, Edward C. ; Parnham, Michael J., editor ; Tak, Paul-Peter, editor

New Therapeutic Targets in Rheumatoid Arthritis. :207-220
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

25
Future molecular targets

von Keystone, Edward C. ; Haraoui, Boulos ; Parnham, Michael J., editor ; et al.

Antirheumatic Therapy: Actions and Outcomes. :69-80
- View full text via DOI
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag